Nexus Surgical & Medicare Intrinsic Value
NEXUSSURGL Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹12.00 | ₹9.60 - ₹14.40 | -31.6% | EPS: ₹1.00, Sector P/E: 12x |
| Book Value Method | asset | ₹3.51 | ₹3.16 - ₹3.86 | -80.0% | Book Value/Share: ₹1.67, P/B: 0.8x |
| Revenue Multiple Method | revenue | ₹10.00 | ₹9.00 - ₹11.00 | -43.0% | Revenue/Share: ₹10.00, P/S: 1.0x |
| EBITDA Multiple Method | earnings | ₹8.33 | ₹7.50 - ₹9.16 | -52.5% | EBITDA: ₹1.00Cr, EV/EBITDA: 5x |
| PEG Ratio Method | growth | ₹13.76 | ₹12.38 - ₹15.14 | -21.6% | EPS Growth: 17.2%, Fair P/E: 13.8x |
| Growth Adjusted P/E | growth | ₹8.60 | ₹7.74 - ₹9.46 | -51.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹26.67 | ₹24.00 - ₹29.34 | +52.0% | ROE: 100.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹5.26 | ₹4.73 - ₹5.79 | -70.0% | EPS: ₹1.00, BVPS: ₹1.67 |
Want to compare with current market value? Check NEXUSSURGL share price latest .
Valuation Comparison Chart
NEXUSSURGL Intrinsic Value Analysis
What is the intrinsic value of NEXUSSURGL?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Nexus Surgical & Medicare (NEXUSSURGL) is ₹10.00 (median value). With the current market price of ₹17.55, this represents a -43.0% variance from our estimated fair value.
The valuation range spans from ₹3.51 to ₹26.67, indicating ₹3.51 - ₹26.67.
Is NEXUSSURGL undervalued or overvalued?
Based on our multi-method analysis, Nexus Surgical & Medicare (NEXUSSURGL) appears to be trading above calculated value by approximately 43.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 2.00 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 100.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 13.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 3.00x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Nexus Surgical & Medicare
Additional stock information and data for NEXUSSURGL
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |